Prevalence and risk factors for disability in leprosy patients in Indonesia during the post-elimination era
https://doi.org/10.4081/dr.2023.9777
HTML: 1
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Leprosy has been nationally eliminated in Indonesia, but it continues to be a public health problem, with disability contributing to the disease burden. Disability caused by leprosy often results in stigmatization, leading to decreased quality of life. This was a retrospective cross-sectional study using secondary data from primary healthcare centers in one of the districts in the region with the highest number of leprosy patients in Indonesia. All leprosy patients between 2016-2022 were included. Among 189 leprosy patients (mean age 46 years old, 65.6% male), 19% had grade 1 disability and 29.6% had grade 2 disability. Duration of disease, nerve enlargements, leprosy reactions, and symmetric lesions were identified as risk factors for both grade 1 and 2 disability. Being male and having a positive smear test was associated with a higher risk of only grade 2 disability. Disability due to leprosy is still prevalent in the post-elimination era despite the decline in new leprosy cases. Improvement in early case detection and prevention of disability are still needed in the post-elimination era.
World Health Organization. Towards zero leprosy global leprosy (hansen’s disease) strategy 2021-2030. World Health Organization; New Delhi: 2021. pp 5-25.
Indonesian Ministry of Health. Mari bersama hapuskan stigma dan diskriminasi kusta di masyarakat. 2022. Available from: http://p2p.kemkes.go.id/mari-bersama-hapuskan-stigma-dan-diskriminasi-kusta-di-masyarakat/ Accessed on January 20, 2023.
Kang S, Amagai M, Bruckner A, et al. Fitzpatrick’s dermatology. 9th ed. New York: McGraw Hill; 2019: pp 2892-924.
Indonesian Ministry of Health. Peraturan Menteri Kesehatan Republik Indonesia Nomor 11 tahun 2019 tentang Penanggulangan Kusta. Indonesia. Available from: http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No__11_Th_2019_ttg_Penanggulangan_Kusta.pdf Accessed on January 22, 2023.
Mowla MR, Ara S, Tripura S. Leprosy profiles in post-elimination stage: a tertiary care hospital experience. Int J Dermatol 2015;54:1407-13.
World Health Organization. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization, Regional Office for South-East Asia; 2018.
Dharmawan Y, Fuady A, Korfage I, Richardus JH. Individual and community factors determining delayed leprosy case detection: a systematic review. PLoS Negl Trop Dis 2021;15:1-17.
Urgesa K, de Bruijne ND, Bobosha K, et al. Prolonged delays in leprosy case detection in a leprosy hot spot setting in Eastern Ethiopia. PLoS Negl Trop Dis 2022;16.
Menaldi SL, Harini M, Nelfidayani N, et al. Functional activity limitation of leprosy cases in an endemic area in Indonesia and recommendations for integrated participation program in society. PLoS Negl Trop Dis 2022;16.
Brakel WH, Sihombing B, Djarir H, et al. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Glob Health Action 2012;5:1-11.
Indonesian Ministry of Health. Leprosy data validation report 2021. Ministry of Health, Directorate General of Diseases Prevention and Control; 2022. Available from: https://p2pm.kemkes.go.id/storage/informasi-publik/content/informasi-publik_18_20220718073519.pdf Accessed on January 26, 2023.
Adriaty D, Prakoeswa CRS, Iswahyudi, et al. Leprosy transmission in endemic and non-endemic areas based on the profile of antibody response of PGL-1 and PCR detection of Mycobacterium leprae DNA from nasal swab among healthy children of East Java, Indonesia. Infect Dis Rep 2020;12:109-12.
Kumar A, Husain S, Murthy BN. Burden of leprosy-related disability: results of a population survey in two states in India. Lepr Rev 2018;353–61.
Shetty VP, Thakar UH, D’Souza E, et al. Detection of previously undetected leprosy cases in a defined rural and urban area of Maharashtra, Western India. Lepr Rev 2009;80:22-33.
Prakoeswa CRS, Lubis RS, Anum Q, et al. Epidemiology of leprosy in Indonesia: a retrospective study. Berk Ilmu Kesehat Kulit dan Kelamin 2022;34:29-35.
Geani S, Rahmadewi, Astindari, et al. Risk factors for disability in leprosy patients: a cross-sectional study. Bali Med J 2022;11:197-201.
Rathod SP, Jagati A, Chowdhary P. Disabilities in leprosy: an open, retrospective analyses of institutional records. An Bras Dermatol 2020;95:52-6.
Mowla MR, Angkur DM, Hasan Z, et al. Leprosy patients with deformities at post-elimination stage: The Bangladesh experience. Skin Health Dis 2021;1:1-8.
Reyila V, Betsy A, Riyaz N, et al. Clinico-epidemiological study of disability due to leprosy at the time of diagnosis among patients attending a tertiary care institution. Indian J Dermatol 2019;64:106-11.
Batista KT, Monteiro GB, Y-Schwartzman UP, et al. Treatment of leprosy-induced plantar ulcers. Rev Brasil Cirurgia Plastica 2019;34:497-503.
World Health Organization. Global leprosy strategy 2016-2020 accelerating towards a leprosy-free world. New Delhi: World Health Organization, Regional Office for South-East Asia; 2016.
Chen X, Liu HB, Shui TJ, Zha S. Risk factors for physical disability in patients with leprosy disease in Yunnan, China: evidence from a retrospective observational study. PLoS Negl Trop Dis 2021;15:1-14
Chu T, Liu D, Huai P, et al. Comprehensive measures succeeded in improving early detection of leprosy cases in post-elimination era: Experience from Shandong Province, China. PLoS Negl Trop Dis 2020;14:1-12.
Quilter EEV, Butlin CR, Singh S, et al. Patients with skin smear positive leprosy in Bangladesh are the main risk factor for leprosy development: 21-year follow-up in the household contact study (Cocoa). PLoS Negl Trop Dis 2020;14:1-13.
Moschioni C, Antunes CMF, Grossi MAF, Lambertucci JR. Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy. Rev Soc Bras Med Trop 2010;43:19-22.
Sarkar J, Dasgupta A, Dutt D. Disability among new leprosy patients, an issue of concern: An institution based study in an endemic district for leprosy in the state of West Bengal, India. Indian J Dermatol Venereol Leprol 2012;78:328-34.
Santos VS, Mayara A, Matos SD, et al. Clinical variables associated with disability in leprosy cases in northeast Brazil. J Infect Dev Ctries 2015;9:232-8.
Raposo MT, Reis MC, Caminha AV, et al. Grade 2 disabilities in leprosy patients from Brazil: need for follow-up after completion of multidrug therapy. PLoS Negl Trop Dis 2018;38:1-12.
Shumet T, Demissie M, Bekele Y. Prevalence of disability and associated factors among registered leprosy patients in all africa Tb and Leprosy Rehabilitation and Training Centre (ALERT), Addis Ababa, Ethiopia. Ethiop J Health Sci 2015;25:313-20.
Mulugeta SS, Maseresha BM, Wassihun SG, Moyehodie YA. Risk factors for disability upgrading among leprosy patients during treatment: multilevel modelling analysis. SAGE Open Nurs 2022;8.
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
